When the Oncology Care Model (OCM) was coming to an end, there was much excitement around its replacement model, the Enhancing Oncology Model (EOM). Unfortunately, with downside risk being mandatory from the outset, The Center for Medicare and Medicaid Innovation...
EOM Participants must take downside risk for all performance periods. They will choose from one of two risk arrangement (RA) options: RA 1: To qualify for savings, participants must reduce expenditures by more than 4% off the benchmark (96% of the benchmark, or the...
5 Year Model; 6-Month Performance Periods (“PPs”) Begins 7/2023; Applications Due 9/30/22 Total cost of care (TCC) model, available to practices and payors. 7 Cancers: Breast, Chronic Leukemia, Small Intestine/ Colorectal, Lung, Lymphoma, Multiple Myeloma, Prostate....
Brian S. Kern, Esq. In 2019, the US spent $3.8 Trillion on healthcare. At 18% of GDP, this figure is neither affordable nor sustainable. Efforts by the federal government to rein in healthcare spending have been met with fierce resistance from corporate interest...
